• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pacific Biosciences (NQ: PACB )

    1.600 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 500
    Open 1.600
    Bid (Size) 1.540 (13)
    Ask (Size) 1.560 (6)
    Prev. Close 1.600
    Today's Range 1.600 - 1.600
    52wk Range 1.160 - 11.96
    Shares Outstanding 247,079,374
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Applied Materials, Amcor, RLX Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Analyst Scoreboard: 5 Ratings For Pacific Biosciences
    Via Benzinga

    Performance

    YTD
    -83.32%
    -83.32%
    1 Month
    -21.95%
    -21.95%
    3 Month
    -14.67%
    -14.67%
    6 Month
    -69.41%
    -69.41%
    1 Year
    -83.87%
    -83.87%

    More News

    Read More
    Peering Into Pacific Biosciences's Recent Short Interest
    Via Benzinga
    PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices
    Via ACCESSWIRE
    How Is The Market Feeling About Pacific Biosciences?
    Via Benzinga
    Expert Outlook: Pacific Biosciences Through The Eyes Of 10 Analysts
    Via Benzinga
    Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts
    Via Benzinga
    UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Strategic Buy Lights Up This Biotech Stock: Time to Invest?
    Via MarketBeat
    Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
    Via InvestorPlace
    Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
    Via Benzinga
    Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
    Via Benzinga
    Topics ETFs
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.